1. Determine the weighted average cost of capital (WACC) for Vigour Pharmaceuticals.
use the following Formulae:
WACC: (E/ V) x R e + ( D/ V) x R d x (1-Tc)
whereas:
E is for Equity ( market value of firm's equity)
D is for Debt ( market value of firm's dept)
V is for Value ( combine market value which is D + E)
R e is the cost of equity
R d is the cost of debt
Tc is the corporate tax rate
Transcribed Image Text:Other relevant information is as follows:
į. The 20-year Treasury Bond rate is currently 4.5 percent and you have estimated market-risk premium to be 6.75 percent
using the returns on stocks and Treasury bonds.
ii. Vigour Pharmaceuticals has a marginal tax rate of 35 percent. In the event of a negative taxable income, the tax is
computed as usual and is reported as a negative number, indicating a reduction in loss after tax.
As a recent graduate of a university, The General Manager of the company has hired you to work alongside the Financial
Controller of the company to help determine whether the company should invest in the new product line. He has provided
you with the following questions to guide you in your assessment of the project and to present your findings to the
Company.
Transcribed Image Text:Vigour Pharmaceuticals Ltd. is considering investing in a new production line for its pain-reliever medicine for
individuals who suffer from cardio vascular diseases. The company has to invest in equipment which costs $2,500,000
and will be depreciated under the MACRS system for a 5-year asset class. It is expected to have a scrap value of $700,000
at the end of the project. Other than the equipment, the company needs to increase its cash and cash equivalents by
$100,000, increase the level of inventory by $30,000, increase accounts receivable by $250,000 and increase account
payable by $50,000 at the beginning of the project. Vigour Pharmaceuticals expect the project to have a life of five years.
The company would have to pay for transportation and installation of the equipment which has an invoice price of
$450,000. The company has already invested $75,000 in Research and Development and therefore expects a positive
impact on the demand for the new pain-reliever. Expected annual sales for the product in the first three years are $600,000
and $850,000 in the following two years. The variable costs of production are projected to be $267,000 per year in years
one to three and $375,000 in years four and five. Fixed overhead is $180,000 per year over the life of the project. The
introduction of the new line of pain reliever will cause a net decrease of $50,000 in profit contribution due to a decrease in
sales of the other lines of pain relievers produced by the company. By investing in the new product line Vigour
Pharmaceuticals would have to use a packaging machine which the company already has. It is fully depreciated and could
be sold at the end of the project for $350,000 after-tax in the equipment market. The company's financial analyst has
advised Vigour Pharmaceuticals to use the weighted average cost of capital as the appropriate discount rate to evaluate the
project. The following information about the company's sources of financing is provided below:
a. The company will contract a new loan in the sum of $2,000,000 that is secured by machinery and the loan has an
interest rate of 6 percent.
b. Vigour Pharmaceuticals has also issued 4,000 new bond issues with an 8 percent coupon, paid semi-annually and
matures in 10 years. The bonds were sold at par, and incurred floatation cost of 2 percent per issue.
c. The company's preferred stock pays an annual dividend of 4.5 percent and is currently selling for $60, and there are
100,000 shares outstanding.
d. There are 300,000 million shares of common stock outstanding, and they are currently selling for $21 each. The beta on
these shares is 0.95.
Definition Definition Amount of return a company generally pays to its equity investors. The cost of equity represents the compensation required by the market in lieu of owning the asset firm and simultaneously bearing the risk of ownership.
Expert Solution
This question has been solved!
Explore an expertly crafted, step-by-step solution for a thorough understanding of key concepts.
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, finance and related others by exploring similar questions and additional content below.
Stephen A. Ross Franco Modigliani Professor of Financial Economics Professor, Randolph W Westerfield Robert R. Dockson Deans Chair in Bus. Admin., Jeffrey Jaffe, Bradford D Jordan Professor
Stephen A. Ross Franco Modigliani Professor of Financial Economics Professor, Randolph W Westerfield Robert R. Dockson Deans Chair in Bus. Admin., Jeffrey Jaffe, Bradford D Jordan Professor
